NBI‐98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double‐blind, placebo‐controlled study

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8257|30|12|1681-1687

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.30, Iss.12, 2015-10, pp. : 1681-1687

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retraction statement: The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double‐blind placebo‐controlled and randomized study

By  

BJU INTERNATIONAL, Vol. 115, Iss. 3, 2015-03 ,pp. : E11-E11

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study

By Varenna Massimo  

British Journal of Rheumatology , Vol. 52, Iss. 3, 2013-03 ,pp. : 534-542

Oxford University Press

Access to resources Recommend Favorite

Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double‐blind, placebo‐controlled study

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 3, 2015-03 ,pp. : 304-308

John Wiley & Sons Inc

Access to resources Recommend Favorite

Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double‐blind, and placebo‐controlled study

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 132, Iss. 4, 2015-10 ,pp. : 270-277

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early botulinum toxin treatment for spastic pes equinovarus – a randomized double‐blind placebo‐controlled study

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 21, Iss. 8, 2014-08 ,pp. : 1089-1095

John Wiley & Sons Inc

Access to resources Recommend Favorite